Lew Lim 
Founder and CEO | VieLight
Toronto, ON, CANADA
Lew Lim is the founder and CEO of VieLight
Spotlight
Media
Publications:
Photos:
Videos:
Audio:
Biography
Dr. Lew Lim is the Founder & CEO of Vielight Inc., and is the inventor of the devices offered by the company. He is a leader in translating the science of photobiomodulation (PBM) into wearable and personal use products, particularly in the field of neurology and neuro science. Today, he directs much of his energy in the search of a solution for Alzheimer’s disease and other brain diseases using PBM. He is also actively pursuing to realize the potential of PBM to address other medical conditions and to enhance human potential. His education and training comprises of engineering, neuroscience, natural medicine, finance, accountancy and management. He obtained his degrees and diplomas from University of California at Berkeley, University of Sheffield, Quantum University, Duke University and The Institute of Chartered Management Accountants, UK.
Areas of Expertise (5)
Medical Devices
Phototherapy
Start-Ups
Corporate Planning
Entrepreneurship
Education (5)
University of California, Berkeley: Graduate Certificate, Engineering 2002
Quantum University: DNM, Natural Medicine
Quantum University: Ph.D., Natural Medicine
Trinity School of Natural Health: Doctor of Naturopathy, Natural Medicine
The University of Sheffield: MBA, Finance
Affiliations (1)
- MedicLights Research Inc. : President and Founder
Languages (2)
- English
- Malay
Media Appearances (1)
Medical startups seek healthy growth abroad
The Globe and Mail
2017-11-01
The technology is based on discoveries made by Vielight's chief executive officer and founder, Lew Lim, who worked in Silicon Valley to pioneer the technique of introducing therapeutic photonic (light) energy into the human body...
Patents (3)
Self-administrable method, system and apparatus for non-invasive neurostimulation therapy of the brain
13/986,768
2013-06-04
The present invention is a portable non-invasive apparatus, system, and method for performing light therapy or photobiomodulation upon the brain tissues through the nostrils of a living mammalian subject for the medical purpose of stimulating the brain in-vivo. In marked difference to conventionally known therapeutic procedures, the present invention utilizes the intranasal pathway as the point of...
Method and portable system for non-invasive, in-vivo blood irradiation light therapy
8535361
2010-06-16
The present invention is a non-invasive apparatus, system, and method for performing irradiation light therapy upon blood circulating within the nostrils of a living mammalian subject. The merit and medical value of the invention resides in its ability to achieve a reversal of red blood cell aggregation in-vivo without invading the tissues or organs of the living subject—a clinical result which...
Using internet content as a means to establish live social networks by linking internet users to each other who are simultaneously engaged in the same and/or similar content
8117281
2007-11-02
A system and method that uses internet content and/or content metadata as a means to establish social networks. Examples include linking internet users, searchers, viewers and/or listeners of the same and/or similar internet content to each other via a platform that enables any of the following in n-dimensional environments: social networking, communications, sharing, e-commerce, advertising,...
Articles (2)
Intranasal photobiomodulation improves Alzheimer’s condition in case studies
Presented at the NAALT/WALT ConferenceSeptember 2014 In photobiomodulation, cells (with mitochondria) that are not in homeostasis normally enters into the process of restoring homeostasis when exposed to low intensity light in the red to near infrared red wavelengths. This same has been observed in the neurons of nerve cells that are under oxidative stress. If low intensity light in the red to near infrared red can reach degenerating neurons, as in...
The potential of intranasal light therapy for brain stimulation
Presented at the NAALT Conference, Palm Beach Gardens, FloridaFebruary 2013 Available evidence supports intranasal light therapy for brain-related conditions such as mild cognitive impairment, Parkinson’s Disease, migraine, stroke. However, the present set of parameters has been based on optimising the results for blood irradiation; which may be holding back its potential for better neurological outcomes. We analysed the literature to arrive at reference parameters for...
